1. Home
  2. FSBW vs ABEO Comparison

FSBW vs ABEO Comparison

Compare FSBW & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSBW
  • ABEO
  • Stock Information
  • Founded
  • FSBW 1936
  • ABEO 1974
  • Country
  • FSBW United States
  • ABEO United States
  • Employees
  • FSBW N/A
  • ABEO N/A
  • Industry
  • FSBW Banks
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FSBW Finance
  • ABEO Health Care
  • Exchange
  • FSBW Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • FSBW 322.3M
  • ABEO 350.2M
  • IPO Year
  • FSBW 2012
  • ABEO 1980
  • Fundamental
  • Price
  • FSBW $41.88
  • ABEO $6.84
  • Analyst Decision
  • FSBW Hold
  • ABEO Strong Buy
  • Analyst Count
  • FSBW 1
  • ABEO 6
  • Target Price
  • FSBW $44.00
  • ABEO $18.17
  • AVG Volume (30 Days)
  • FSBW 16.8K
  • ABEO 709.1K
  • Earning Date
  • FSBW 10-21-2025
  • ABEO 08-14-2025
  • Dividend Yield
  • FSBW 2.65%
  • ABEO N/A
  • EPS Growth
  • FSBW N/A
  • ABEO N/A
  • EPS
  • FSBW 4.15
  • ABEO 0.99
  • Revenue
  • FSBW $139,676,000.00
  • ABEO $400,000.00
  • Revenue This Year
  • FSBW $9.62
  • ABEO N/A
  • Revenue Next Year
  • FSBW $5.35
  • ABEO $339.63
  • P/E Ratio
  • FSBW $10.16
  • ABEO $6.97
  • Revenue Growth
  • FSBW 0.61
  • ABEO N/A
  • 52 Week Low
  • FSBW $34.61
  • ABEO $3.93
  • 52 Week High
  • FSBW $49.15
  • ABEO $7.54
  • Technical
  • Relative Strength Index (RSI)
  • FSBW 54.56
  • ABEO 53.31
  • Support Level
  • FSBW $41.95
  • ABEO $6.77
  • Resistance Level
  • FSBW $42.75
  • ABEO $7.05
  • Average True Range (ATR)
  • FSBW 0.97
  • ABEO 0.24
  • MACD
  • FSBW 0.07
  • ABEO -0.03
  • Stochastic Oscillator
  • FSBW 71.88
  • ABEO 25.36

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: